Diagnomics
Diagnomics provides genome sequencing and AI-driven analysis to enable precision medicine and clinical research. The company combines next-generation sequencing, microarray platforms, Illumina sequencing, QuantStudio real-time PCR, and cloud-based bioinformatics to deliver CLIA- and CAP-accredited genetic testing and interpretation. Its AiGenomics platform applies artificial intelligence and genome analysis pipelines to annotate variants and produce actionable insights for researchers, clinicians, and consumers. Diagnomics operates as a hybrid SaaS and services provider, offering assay deployment, translational research support, and clinical laboratory testing. The company serves pharmaceutical and biotech firms, academic institutions, hospitals, physicians, and individual consumers seeking personalized genomic information.
Diagnomics
Diagnomics provides genome sequencing and AI-driven analysis to enable precision medicine and clinical research. The company combines next-generation sequencing, microarray platforms, Illumina sequencing, QuantStudio real-time PCR, and cloud-based bioinformatics to deliver CLIA- and CAP-accredited genetic testing and interpretation. Its AiGenomics platform applies artificial intelligence and genome analysis pipelines to annotate variants and produce actionable insights for researchers, clinicians, and consumers. Diagnomics operates as a hybrid SaaS and services provider, offering assay deployment, translational research support, and clinical laboratory testing. The company serves pharmaceutical and biotech firms, academic institutions, hospitals, physicians, and individual consumers seeking personalized genomic information.